ART acquires exclusive licence to patent portfolio

Guest Contributor
December 22, 2003

ART Advanced Research Technologies Inc, Montreal, has bolstered its competitive position in the field of optical molecular imaging following its acquisition of an extensive patent portfolio held by a pioneer in the florescence spectroscopy at the Univ of Maryland. The deal gives the bio-optical imaging company exclusive licensing rights to Dr. Joseph Lakowicz’s extensive optical molecular imaging patent portfolio – technologies that will help in the development of new therapeutic and diagnostic drugs and treatments. Lakowicz, a world renowned biochemist and molecular biologist, also becomes a member of ART’s scientific advisory board. Terms of the deal were not disclosed....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.